# FDA 483 - Alejandro (NMI) Hoberman, M.D. - June 18, 2024

Source: https://www.globalkeysolutions.net/records/483/alejandro-nmi-hoberman-md/75d36ed3-9fec-45b2-bbe9-591be0e3fa52

> FDA 483 for Alejandro (NMI) Hoberman, M.D. on June 18, 2024. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Alejandro (NMI) Hoberman, M.D.
- Inspection Date: 2024-06-18
- Product Type: drugs
- Office Name: Philadelphia District Office
- Summary: Alejandro (NMI) Hoberman, M.D., a clinical investigator in Pittsburgh, PA, was cited for a single observation during an FDA inspection from June 12-18, 2024. The observation detailed a failure to meet general informed consent requirements, specifically that a parent fluent only in Spanish signed an English consent form for their child. Reconsent was subsequently obtained using a Spanish translated version of the consent form.

## Related Officers

- [Cynthia L. Rakestraw](https://www.globalkeysolutions.net/people/cynthia-l-rakestraw/ca138abf-e5d4-43ca-b9d2-79ea6294a8c8)

Company: https://www.globalkeysolutions.net/companies/alejandro-nmi-hoberman-md/d78906f3-7db2-4f93-ba44-d21657343105

Office: https://www.globalkeysolutions.net/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8